Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia-Reference-Cited by-同舟云学术

Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia

Published:2015-09-15 Issue:2 Volume:59 Page:504-530
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Roecker Anthony J.¹,Cox Christopher D.¹,Coleman Paul J.¹

Affiliation:

1. Department of Medicinal Chemistry, Merck Research Laboratories, P.O. Box 4, 770 Sumneytown Pike, WP14-2, West Point, Pennsylvania 19486, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5b00832

Reference107 articles.

1. Insomnia market

2. The hyperarousal model of insomnia: A review of the concept and its evidence

3. Essentials of Polysomnography: A Training Guide and Reference for Sleep Technicians

4. The treatments of chronic insomnia: A review of benzodiazepine receptor agonists and psychological and behavioral therapies

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seven-membered N-heterocycles as approved drugs and promising leads in medicinal chemistry as well as the metal-free domino access to their scaffolds;European Journal of Medicinal Chemistry;2024-09

2. G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery;Signal Transduction and Targeted Therapy;2024-04-10

3. The Orexinergic System: Neurobiology and Clinical Implications;Annals of Indian Psychiatry;2024-04

4. Pyrazole derivatives as selective orexin-2 receptor antagonists (2-SORA): synthesis, structure–activity–relationship, and sleep-promoting properties in rats;RSC Medicinal Chemistry;2024

5. Harnessing conformational drivers in drug design;Progress in Medicinal Chemistry;2024